Pricing Log in Create free account

GeoVax Labs Inc. (GOVX) vs Virax Biolabs Group Limited (VRAX)

GeoVax Labs Inc. and Virax Biolabs Group Limited are both Biotechnology companies. GeoVax Labs Inc. and Virax Biolabs Group Limited are of similar size ($1.6M and $1.6M). Across the 10 metrics below, GeoVax Labs Inc. leads on 5 and Virax Biolabs Group Limited on 5.

Valuation

Metric GOVX VRAX Biotechnology median
P/E n/m n/m 10.60
P/S 0.11 — 9.40
P/B 0.39 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.10 0.86 0.66
EV/Sales (0.33) n/m 9.02
Earnings yield (9,086.67%) (642.17%) (32.88%)
Free cash flow yield (2,686.72%) 0.00% (23.13%)

Profitability

Metric GOVX VRAX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (891.59%) 0.00% (51.96%)
Return on assets (408.79%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GOVX VRAX Biotechnology median
Revenue growth (TTM) 963.56% — 6.76%
EPS growth (last fiscal year) 81.41% 68.79% 29.88%
Revenue growth, 5-year CAGR 16.18% (36.88%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GOVX VRAX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.54 9.97 4.97
Net debt to EBITDA 0.14 1.08 1.01

Dividend

Metric GOVX VRAX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GOVX VRAX Biotechnology median
Market cap 1.60m 1.58m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack